Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Arthrex, Inc.
The Medtech 100 Ranking: A Successful Year But Industry Must Tread Carefully In 2023
Medtech Insight’s just-published ranking of the leading global medtechs based on revenues reported for fiscal 2021 reveals a picture of an industry overwhelmingly in growth, despite – or in some cases because of – the persistent effects of the pandemic.
Judge Jackson’s Patent, FDA Rulings Show She Is ‘Super Smart’ And Would Be Beneficial For Pharma
Supreme Court nominee issued three decisions on Hatch-Waxman regime as district court judge, including case in which she ruled against the FDA’s denial of orphan drug designation and another in which she deferred to the agency’s view on exclusivity. Her analysis of facts may play a role if the court takes up a case on administrative agency deference.
DOJ Anti-Fraud Actions Include $16M Kickback Settlement For Arthrex
Arthrex reportedly paid a physician to use the company’s orthopedic products. Separately, multiple telehealth-related false-billing schemes landed six men in hot water.
Fracture Fixation Devices Market Projected A Return To Steady Growth
A new Informa Meddevicetracker report outlines projections for the fracture fixation devices market.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- MX Orthopedics
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.